본문 바로가기
KERD
논문KCI 등재

Multistaining Optimization for Epstein-Barr Virus–Encoded RNA In Situ Hybridization and Immunohistochemistry of Formalin-Fixed Paraffin-Embedded Tissues Using an Automated Immunostainer

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Single staining is commonly performed for practical pathologic diagnoses. However, this method is limited in its ability to specify cellular morphology and immunophenotype and often requires consumption of limited tissue. This study aimed to describe an optimized protocol for multiple in situ hybridization (ISH) and immunohistochemistry (IHC). Methods: The quality of multistaining was evaluated by carefully changing each step of ISH and IHC in an angioimmunoblastic T-cell lymphoma (AITL) case on a Ventana Bench-Mark XT automated immunostainer. The optimized protocols were also performed using another immunostainer and in 15 cases of five Epstein-Barr virus (EBV)–associated malignancies using formalin-fixed paraffin-embedded tissue. Results: The quality of various ISH-IHC staining protocols was semi-quantitatively evaluated. The best EBV-encoded RNA (EBER)-ISH/double IHC staining quality, equivalent to single staining, was obtained using the following considerations: initial EBER-ISH application, use of protease and antigen retrieval reagent (cell conditioning 1 [CC1] treatment time was minimized due to impact on tissue quality), additional baking/deparaffinization not needed, and reduced dilution ratio and increased reaction time for primary antibody compared with single immunostaining. Furthermore, shorter second CC1 treatment time yielded better results. Multiple staining was the best quality in another immunostainer and for different types of EBV-associated malignancies when it was performed in the same manner as for the Ventana BenchMark XT as determined for AITL. Conclusions: EBER-ISH and double IHC could be easily used in clinical practice with currently available automated immunostainers and adjustment of reagent treatment time, dilution ratio, and antibody reaction time.

Abstract

Background: Single staining is commonly performed for practical pathologic diagnoses. However, this method is limited in its ability to specify cellular morphology and immunophenotype and often requires consumption of limited tissue. This study aimed to describe an optimized protocol for multiple in situ hybridization (ISH) and immunohistochemistry (IHC). Methods: The quality of multistaining was evaluated by carefully changing each step of ISH and IHC in an angioimmunoblastic T-cell lymphoma (AITL) case on a Ventana Bench-Mark XT automated immunostainer. The optimized protocols were also performed using another immunostainer and in 15 cases of five Epstein-Barr virus (EBV)–associated malignancies using formalin-fixed paraffin-embedded tissue. Results: The quality of various ISH-IHC staining protocols was semi-quantitatively evaluated. The best EBV-encoded RNA (EBER)-ISH/double IHC staining quality, equivalent to single staining, was obtained using the following considerations: initial EBER-ISH application, use of protease and antigen retrieval reagent (cell conditioning 1 [CC1] treatment time was minimized due to impact on tissue quality), additional baking/deparaffinization not needed, and reduced dilution ratio and increased reaction time for primary antibody compared with single immunostaining. Furthermore, shorter second CC1 treatment time yielded better results. Multiple staining was the best quality in another immunostainer and for different types of EBV-associated malignancies when it was performed in the same manner as for the Ventana BenchMark XT as determined for AITL. Conclusions: EBER-ISH and double IHC could be easily used in clinical practice with currently available automated immunostainers and adjustment of reagent treatment time, dilution ratio, and antibody reaction time.

참고문헌 (12)

  1. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues" (2017), International Agency for Research on Cancer
  2. Coiffier B, "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", N Engl J Med, 346, pp.235~242 (2002)
  3. Wu L, "Cancer biomarker detection : recent achievements and challenges", Chem Soc Rev, 44, pp.2963~2997 (2015)
  4. Isidro RA, "Double immunofluorescent staining of rat macrophages in formalinfixed paraffin-embedded tissue using two monoclonal mouse antibodies", Histochem Cell Biol, 144, pp.613~621 (2015)
  5. Ojima T, "Advantages of the rapid double-staining method for intraoperative detection of micrometastasis in sentinel lymph nodes", Oncol Rep, 30, pp.1067~1072 (2013)
  6. Van der Hauwaert C, "Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10", CD13 double labeling, 2013, pp.8, e66750~
  7. Jeziorski E, "Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled seroepidemiological study, and in situ analysis", PLoS One, 3, pp.e3262~ (2008)
  8. Bankfalvi A, "Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use : a comparative methodological study using the Ventana BenchMark automated staining system and manual tests", Int J Oncol, 25, pp.929~935 (2004)
  9. Weisenburger DD, "Peripheral T-cell lymphoma, not otherwise specified : a report of 340 cases from the International Peripheral T-cell Lymphoma Project", Blood, 117, pp.3402~3408 (2011)
  10. Terragni R, "EGFR, HER-2 and KRAS in canine gastric epithelial tumors : a potential human model", PLoS One, 9, pp.e85388~ (2014)
  11. Shi SR, "Antigen retrieval in formalin-fixed, paraffin-embedded tissues : an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections", J Histochem Cytochem, 39, pp.741~748 (1991)
  12. Van der Loos CM, "Chromogens in multiple immunohistochemical staining used for visual assessment and spectral imaging : the colorful future", J Histotechnol, 33, pp.31~40 (2010)

관련 논문AI추천

The Prognostic Subgroups as Defined by the Patterns of Epstein-Barr Virus Infection in Patients with Hodgkin Lymphoma고영혜, 김석진, 김원석, 노지현대한병리학회 · Journal of Pathology and Translational Medicine2010 · 제44권 제1호Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips노진, 김소운, 박찬식대한병리학회 · Journal of Pathology and Translational Medicine2016 · 제50권 제6호Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification고영혜, 김지은, 김현정, 박경신, 백진호, 이승숙, 이혜경, 차희정, 최유덕, 한재호, 허주령대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제4호High-Throughput Multiplex Immunohistochemical Imaging of the Tumor and Its Microenvironment김진, 고지원, 곽윤진, 김우호대한암학회 · Cancer Research and Treatment2020 · 제52권 제1호Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma김세종, 김호근, 노성훈, 박전한, 이원영, 이재면대한면역학회 · Immune Network2011 · 제11권 제1호Angioimmunoblastic T Cell Lymphomas: Frequent Cutaneous Skin Lesions and Absence of Human Herpes Viruses최진, 김명남, 김범준, 윤길숙, 장성은, 최지호, 허주령, Hana Bak, Hye Myung Rheu, Yang Kyu Choi대한피부과학회 · Annals of Dermatology2009 · 제21권 제1호

이 간행물의 다른 논문 (10건)